A phase II study to evaluate the efficacy of bevacizumab in combination with capecitabine and concomitant radiotherapy in patients affected by non-resectable locally advanced pancreatic cancer.
Phase of Trial: Phase II
Latest Information Update: 07 Jun 2011
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 07 Jun 2011 New trial record